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ABSTRACT 
The identification of biological fluids is a precursor to determine if further human 
identification is required in a forensic setting. There are four forensically-relevant 
biological fluids: blood, semen, vaginal epithelial tissue, and saliva. While serological 
testing can identify these tissue types to some degree of accuracy, there has recently been 
momentum in research to use DNA methylation for tissue identification. 
In the current study, five potential tissue-specific methylation markers were 
studied in order to identify locations in the genome that would differentiate saliva from 
other tissue types. Genomic DNA was extracted from each sample, followed by bisulfite 
modification, polymerase chain reaction amplification, and pyrosequencing. 
Pyrosequencing is a sequence by synthesis method that provides quantitative methylation 
data.  The level of significance in methylation data between tissues was calculated using 
SPSS statistical package with a one-way ANOVA and Tukey’s posthoc parameters. Two 
additional studies were completed: a species-specific test and mixture study. 
Five loci, cg-9652652, cg-11536474, cg-3867465, cg-10781408, and cg-
10122865 along with several adjacent CpG sites were found to be hypermethylated in 
saliva. The methylation data of saliva was statistically significant compared to other 
tissues, suggesting these markers can be used to discriminate saliva from other tissue 
types. In the species specificity study, it was observed that the primers used in one of the 
assays were human specific as they did not amplify non-primate samples. A mixture 
study using two different tissues behaved as predicted where a reduction in the 
methylation percent was observed when the quantity of salivary DNA decreased. 
 iii 
ACKNOWLEDGMENTS 
I would like to express my sincerest gratitude to my committee chair, Dr. 
Kuppareddi Balamurugan, along with committee members Dr. Dean Bertram and Dr. 
Xuyang He. Thank you for taking the time to review all my work and support me in the 
research phase of this process. I would also like to thank my friend and fellow graduate 
student Lauren Satcher, who also navigated this process with me and provided immense 
support. Finally, I would also like to express my thanks to faculty of The School of 
Criminal Justice, Forensic Science, and Security for their constant support during my 
academic career at The University of Southern Mississippi. 
 iv 
TABLE OF CONTENTS 
ABSTRACT ........................................................................................................................ ii 
ACKNOWLEDGMENTS ................................................................................................. iii 
LIST OF TABLES ............................................................................................................ vii 
LIST OF ILLUSTRATIONS ........................................................................................... viii 
CHAPTER I - INTRODUCTION ...................................................................................... 1 
Forensic DNA Identification Methods............................................................................ 1 
Forensic Tissue Identification ......................................................................................... 2 
DNA Methylation for Tissue Identification .................................................................... 4 
Methylation Analysis Methods ....................................................................................... 5 
Aims and Objectives ....................................................................................................... 6 
CHAPTER II – REVIEW OF LITERATURE ................................................................... 8 
Current Tissue Identification Methods ........................................................................... 8 
Blood ........................................................................................................................... 8 
Semen ........................................................................................................................ 10 
Vaginal Epithelial tissue ........................................................................................... 11 
Saliva......................................................................................................................... 11 
DNA Methylation Analysis .......................................................................................... 12 
CHAPTER III - MATERIALS AND METHODS ........................................................... 15 
Sample Collection ......................................................................................................... 15 
 v 
DNA Extraction ............................................................................................................ 16 
DNA Quantitation ......................................................................................................... 17 
Bisulfite Conversion ..................................................................................................... 17 
Cleaning the Bisulfite Converted DNA ........................................................................ 18 
Marker Selection and Primer Design ............................................................................ 19 
Amplification of CpG Sites for Pyrosequencing .......................................................... 20 
Pyrosequencing ............................................................................................................. 21 
Pyrosequencing Data Analysis ..................................................................................... 22 
Species Specificity Test ................................................................................................ 22 
CHAPTER IV – RESULTS .............................................................................................. 24 
Marker cg-9652652 ....................................................................................................... 24 
Marker cg-11536474 ..................................................................................................... 25 
Marker cg-3867465 ....................................................................................................... 27 
Marker cg-10781408 ..................................................................................................... 28 
Marker cg-10122865 ..................................................................................................... 29 
Species Test .................................................................................................................. 31 
Mixture Study ............................................................................................................... 32 
CHAPTER V – DISCUSSION ......................................................................................... 33 
APPENDIX A – Primer Specifications ............................................................................ 37 
APPENDIX B –IRB Approval Letter ............................................................................... 38 
 vi 
REFERENCES ................................................................................................................. 39 
 
 vii 
LIST OF TABLES 
Table 1. Bisulfite conversion reaction components per sample ....................................... 17 
Table 2. Thermocycler conditions for bisulfite conversion .............................................. 18 
Table 3. PCR components and corresponding volume for amplification per sample ...... 20 
Table 4. Thermalcycler conditions for polymerase chain reaction amplification ............ 20 
Table 5. Percent Methylation and Standard Deviation for cg-9652652 ........................... 24 
Table 6. Percent Methylation and Standard Deviation for cg-11536474 ......................... 26 
Table 7. Percent Methylation and Standard Deviation for data for cg-3867465 .............. 27 
Table 8.1. Percent Methylation and Standard Deviation for cg-10781408 sites 1-6 ........ 28 
Table 8.2. Percent Methylation and Standard Deviation for cg-10781408 sites 7-11 ...... 28 
Table 9. Percent Methylation and Standard Deviation for cg-10122865 ......................... 30 
Table 10.1 Methylation data obtained for the different species, sites 1-5 ........................ 31 
Table 10.2 Methylation data obtained for different species, sites 6-9 .............................. 31 
 
 
 viii 
LIST OF ILLUSTRATIONS 
Figure 1. Histogram of average methylation data of marker cg-9652652. ....................... 25 
Figure 2. Histogram of the average methylation data of marker cg-11536474. ............... 26 
Figure 3. Histogram of average methylation data of marker cg-3867465 ........................ 27 
Figure 4. Histogram of average methylation data of marker cg-3867465. ....................... 29 
Figure 5. Histogram of average methylation data of marker cg-10122865 ...................... 30 
Figure 6.  Methylation percent averages of mixed samples for cg-9652652, CpG site 2. 32 
  
 
 
 
 1 
CHAPTER I - INTRODUCTION 
Forensic DNA Identification Methods 
Within the last 35 years DNA technology has seen a steady and significant 
advancement, which has positively impacted the ability to identify individuals using 
biological evidence materials. In 1980 Ray White describes the first polymorphic VNTR 
marker; however, the use of DNA for human identification is credited to Alec Jeffreys, 
who developed a Restriction Fragment Length Polymorphism (RFLP) probe in 1985 that 
was able to identify variable number tandem repeat (VNTR) regions that are located 
within the human genome (Butler, 2010).   VNTR regions, as the name implies, are 
genomic regions that contain a variable number of repeats between individuals; however, 
it is because the VNTR regions vary in both number of repeats and in the number of 
nucleotide bases per repeat that they are unique enough to distinguish between 
individuals. Jeffreys is the first to use the RFLP technique to find VNTRs for human 
identification purposes (Butler, 2010). While the RFLP probe was a huge milestone for 
forensic human identification, it was not without its disadvantages. VNTR analysis 
requires DNA that is non-degraded and in a quantity that is at least 100 nanograms 
(Hammond et al., 1994). Neither of these factors can be guaranteed of a DNA sample 
collected from a crime scene. The disadvantages of VNTR analysis prompted the search 
for a human identification technique that could overcome both the high quality and 
quantity barrier.  
 In 1983, a methodology was developed by Kary Mullis, which opened the door 
for the opportunity of a more efficient way of human identification (Saiki et al., 1985). 
This methodology was called polymerase chain reaction (PCR) and gave the ability to 
 2 
amplify small quantities of DNA through successive cycles of systematic heating and 
cooling. PCR involves three main steps in each cycle: denaturation, annealing, and 
extension. The reaction is supplied with primers to bind single-stranded DNA, an excess 
of nucleotides, DNA polymerase enzymes to extend the DNA, and buffers ideal for these 
reactions to take place (Lynch & Brown, 1989). Each cycle effectively doubles the 
amount of DNA present in the sample in a relatively short time span; generally, 
amplification reactions take only a few hours. The ability to amplify DNA has allowed 
for a large advancement in many different branches of the scientific community. 
Forensically, the ability to amplify DNA gives more available sample for analysis. 
Short Tandem Repeat (STR) markers contain a variable number of repeats at 
different locations in the genome that are unique to each individual. The current national 
DNA quality assurance standards call for the analysis of twenty STR markers for human 
identification. These markers are part of the Combined DNA Index System (CODIS), 
which is a DNA database maintained by the Federal Bureau of Investigation. The odds of 
two individuals, excluding identical twins, having the same number of repeats at the 
exact STR markers is virtually impossible. This is why STR markers have become the 
method of choice when comparing evidence from a crime scene to reference samples 
from the person(s) of interest. The ability to amplify DNA has allowed for the creation of 
commercial kits that can amplify specific STR segments of the human genome which are 
currently used for human identification (Romsos & Vallone, 2015).  
Forensic Tissue Identification 
While human identification has seen significant advancement in recent years, 
another aspect of forensic science, serological tests, have not seen similar progress. 
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Serological tests provide information pertaining to the identity of a biological fluid found 
at crime scenes. In identifying the source of the sample, the analyst can then decide what 
further testing may be required. Serological tests fall within two umbrella categories: 
presumptive tests and confirmatory tests. Presumptive tests are a quick means to 
determining what the sample identity could be, and a confirmatory test verifies the 
information gained from the presumptive test. 
Currently there are several standard serological tests that are used to discriminate 
between forensic tissues of interest. Two of the most commonly used presumptive blood 
tests are Hemastix and the use of Phenolphthalein reagent. The presence is confirmed 
using a visual examination of ferroprotoporphyrin crystals that are produced in the 
presence of hemoglobin in the Takayama Crystal Test.  Semen is presumptively 
identified using an Acid Phosphatase reagent, and confirmed using a visual observation 
of stained spermatozoa. There are also ABAcard tests for both blood and sperm, 
respectively, that confirm the presence of the substance in question using antigen-
antibody interactions. Saliva is identified by the presence of an Amylase enzyme, which 
is found in higher quantity in saliva compared to all other biological samples.  
While these tests do help in the discrimination of tissue types, they are not 
without fault. Currently there are no standard tests used to identify vaginal epithelial 
samples. Many of the tests listed above are also not specific to human biological samples, 
could result in false positives or negatives in cases where diluted samples are used, and 
the serological test reagents have the potential to degrade DNA (Gonçalves et al., 2017; 
Tobe et al., 2007; Vennemann et al., 2014).  Some serological tests require a large 
amount sample, a luxury that is not always readily available in forensic casework. Also, 
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any sample that is used up for serological testing cannot then be used for identification 
purposes. This necessitates the need for a more reliable and streamlined protocol for 
forensic tissue identification. 
DNA Methylation for Tissue Identification 
Recently, there has been evidence to support DNA methylation analysis as a 
viable option for forensic tissue identification. DNA methylation is an epigenetic 
modification that occurs either naturally or in response to environmental stimuli such as 
age, smoking status, diet, and tissue type (Vidaki et al., 2013). In this process a methyl 
group is added to a cytosine base without changing the underlying sequence of the DNA 
itself (Li & Zhang, 2012). This type of modification occurs mostly in cytosine bases that 
are immediately followed by guanine bases. For this reason, the sites in the genome 
where this modification occurs are called CpG sites. Areas of the genome that contain a 
large amount of CpG sites in close proximity are called CpG islands (Vidaki, Daniel, & 
Court, 2013). Methylation levels have long been a topic of interest in the medical 
community, as the proximity of these CpG islands to the promoter region of genes can 
have an effect on gene activation or repression. Approximately 60% of all gene 
promoters include a CpG island (Li & Zhang, 2012). When the CpG island is 
unmethylated the promoter region is available for binding allowing for genes to be 
transcribed, when it becomes methylated the response is generally gene inactivation 
(Previti et al., 2009).  
Within the last decade, however, there has been momentum in research to use 
DNA methylation for forensic tissue identification. The tissue source of a biological 
sample has been proven to affect the methylation level for a given sample. Therefore, the 
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main objective of this methylation-related research has been trying to find those CpG 
sites that are specific for the tissue-type in question. In order to do this, a selected CpG 
site must be either hypomethylated for one tissue type and hypermethylated for all others, 
or vice versa. There has been a large amount of success in uncovering blood-specific and 
semen-specific CpG sites (Lee et al., 2012; Madi et al., 2012), however, there have been 
very few vaginal epithelial-specific and saliva-specific CpG sites located.  
Methylation Analysis Methods  
 The level of methylation at a particular CpG site can be found using several 
different methods such as ligation mediated PCR, restriction digestion PCR, and bisulfite 
modification followed by pyrosequencing. Ligation mediated uses enzymes that are 
methylation-sensitive to cut DNA sequences at restriction sites. The amount of enzyme 
activity is quantitated by PCR amplification of the cleaved DNA pieces, which directly 
correlates to the amount of methylation at the restriction site (McGrew & Rosenthal, 
1993). For restriction digestion amplification a methylation-specific restriction enzyme is 
used to cleave restriction sites where methylation is not present. Tissue identification 
markers are amplified with the digested DNA and are fluorescently labeled. These PCR 
products are measured by capillary electrophoresis; the loci with higher methylation 
levels are going to amplify more efficiently and will give a greater signal (Frumkin et al., 
2011).  
A more recent method of methylation analysis can be accomplished by using 
bisulfite conversion techniques followed by pyrosequencing. The purpose of the bisulfite 
modification is to convert all unmethylated cytosine bases in a genomic sample to uracil 
while all the methylated cytosines remain as methylated cytosine (5mc). After the 
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modification, the DNA undergoes site-specific PCR amplification, followed by 
pyrosequencing.  The DNA samples are denatured to single-stranded DNA and are 
exposed to a synthesized sequencing primer that anneals prior to samples entering the 
sequencing process (Delaney, Garg, & Yung, 2015). The single-stranded DNA is then 
synthesized, and with each incorporated nucleotide light is emitted and recorded. The 
amount of guanine or Adenine that is incorporated at a specific CpG site gives 
information about the amount of methylation present at that site in the sample being 
tested (Delaney, Garg, & Yung, 2015). If the same approximate level of methylation is 
seen at CpG sites across several samples, that methylation data can be compared to data 
for the same CpG site in other tissue samples. For the purposes of tissue discrimination, 
there needs to be a consistent trend of hypomethylation for one tissue while all others 
remain hypermethylated and vice versa.  Pyrosequencing technology is advantageous for 
methylation analysis since it provides quantitative methylation data that can be used for 
tissue to tissue comparison. 
Aims and Objectives 
The main objective of this study is to locate a set of CpG sites that contain 
methylation levels consistent enough to discriminate saliva cells from other bio-fluids of 
forensic interest such as blood, vaginal epithelial tissue, and sperm. Ideally, if these CpG 
sites could be located for saliva, the data could be combined with methylation data for 
other tissue types to develop an assay capable of identifying the tissue source of an 
unknown DNA sample.  Development of multiple markers for saliva identification will 
reduce the error rate in tissue identification.  Since the DNA is already available for 
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forensic case work, there is no need to expend additional evidentiary item for this 
analysis. 
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CHAPTER II – REVIEW OF LITERATURE 
Current Tissue Identification Methods 
Currently, several presumptive and confirmatory tests exist as a whole for the 
identification of forensically-relevant body fluids.  While these tests have become 
standard in many serological laboratories, they do have certain limitations.  Many of 
these serological methods lack in either specificity or sensitivity, which can lead to false 
positive or false negative results.   
Blood 
One of the most common biological fluids found at crime scenes is blood.  The 
presumptive tests for blood can be divided into two categories, namely catalytic color test 
and chemiluminescent test.  The catalytic color test involves the change of color of the 
reagent used while chemiluminesence and fluorescence tests both emit light as the end 
product of an oxidation reaction in the presence of hemoglobin, a protein found in blood 
(Cassidy et al., 2017). Chemiluminescence does not require an alternate light source to be 
seen, however fluorescence tests do need an alternate light source to be visualized 
(Vandewoestyne et al., 2015) The most commonly used chemiluminescence test is 
Luminol, a presumptive test that has been found to have a sensitivity of detection for 
blood samples diluted up to 1:100,000 (Tobe et al., 2007).  
 The two most common catalytic color tests are Hemastix and Phenolphthalein. 
Both tests, as the name implies, produce a change in color that corresponds to the 
possible presence of blood in a sample. In a study conducted by Vennemann et al. (2014) 
the group was able to determine that the phenolphthalein presumptive test had a high 
sensitivity for neat blood samples at a 1:10,000,000 dilution, but showed poor results 
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when testing for specificity of blood detection. Hemastix test strips that were developed 
to detect occult blood in urine have found its way in forensic testing as well.  A study 
conducted by Tobe et al. (2007) showed a sensitivity for Hemastix up to 1:100,000, but 
was unsuccessful in detecting blood at dilutions greater than this. The same group also 
tested the specificity of Hemastix using a number of various foods, chemicals, and other 
biological samples and found a large number of non-blood materials gave positive results 
for the test (Tobe et al., 2007). In addition, both catalytic color presumptive tests have 
been reported to cause DNA degradation (Thanakiatkrai et al., 2014). Since presumptive 
positive blood samples will be submitted for further DNA analysis, the DNA degradation 
should be kept to a minimum to the possible extent. 
There are two serological tests that serve as confirmatory tests for the presence of 
blood: Takayama Crystal Test and the use of an ABAcard Hematrace test kit. The 
Takayama Crystal Test employs a Takayama reagent, which when added to a blood 
sample will produce pink colored feather-shaped crystals called pyridine 
ferroprotoporphyrin crystals that can be viewed under a microscope. This test is not 
specific to humans, and therefore cannot be used as a species-specific test, but only a 
confirmatory test. The most commonly used species-specific test for blood is the 
ABAcard Hematrace test card. This card is a one-step chromatographic test that relies on 
the specific reaction between human hemoglobin (Hb) antigens and anti-human 
hemoglobin antibodies (Hurley et al., 2009). The ABAcard Hematrace is described as 
having both high in specificity and sensitivity (Hurley et al., 2009), however it is not 
species specific. The ABAcard Hematrace test has shown positive blood detection results 
for human, primates, and ferrets (Johnston, Newman, & Frappier, 2003). The advantages 
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of this test do outweigh the disadvantages, as it is unlikely that the other species body 
fluids will be found at a crime scene. 
Semen 
Another biological sample of forensic interest is semen, generally present in cases 
where a sexual assault has taken place. Like other biological specimens, both a 
presumptive test and a confirmatory test are used to ascertain the presence of semen or 
spermatozoa. The presumptive test used for semen identification is called acid 
phosphatase, and is a color test that identifies acid phosphatase, which is found in the 
higher quantity in seminal fluid when compared to other secretions. In a study conducted 
by Gonçalves et al. (2017), the group tested the specificity of acid phosphatase 
presumptive test using semen and semen mixed with other biological fluids. It was found 
that The AP test was effective in giving a positive result in the presence of diluted semen 
samples, however was unsuccessful in discriminating between semen and other types of 
biological samples (Gonçalves et al., 2017).  Another limitation of the acid phosphatase 
test is that the amount of acid phosphatase can vary largely between males (Redhead & 
Brown, 2013).  It has also been found that the storage temperatures of the evidence affect 
the activity of acid phosphatase in the semen sample (Gaensslen 1983) 
The two most commonly used confirmatory tests for semen identification are a 
microscopic search of spermatozoa and the detection of a prostate-specific antigen (PSA) 
using ABAcard p30 test strip.  The identification of spermatozoa through a microscope 
has no specificity concerns since the spermatozoa are physically observed by the analyst.  
The only sensitivity concerns arise when there is a male individual who does not produce 
any spermatozoa, but this is a rare occurrence.  
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The ABAcard p30 test strip works for semen detection in the same way as the 
ABAcard Hematrace test strip works for blood detection, through antigen-antibody 
interactions. When a sample contains seminal material, the p30 antigen will bind with the 
anti-p30 antibodies, causing the formation of a colored band in the test kit. The 
previously mentioned study conducted by Gonçalves et al. (2017), also investigated 
specificity and sensitivity of the kit for p30 antigens and found that the kit was highly 
sensitive and specific for the p30 antigens, while other body fluids produced a negative 
result.  (Gonçalves et al., 2017). 
Vaginal Epithelial tissue 
 While there are several serological techniques available for the identification of 
blood and spermatozoa, there is no standard laboratory protocol exists for the 
identification of vaginal epithelial tissue. Earlier methods used for the identification of 
vaginal epithelial cells using glycogen staining were not reliable.   
Saliva 
 Saliva contains an enzyme amylase that is present in higher quantities in saliva 
than other body fluids, making it a prime candidate for possible saliva detection. While 
the detection of saliva is neither a presumptive nor confirmatory test, the quantity of 
amylase in the sample can be used to make conclusions regarding the presence or absence 
of saliva in a sample. Amylase is a starch-hydrolyzing enzyme, used in conjunction with 
an iodine that can stain starch a blue color (Meyers & Adkins, 2008). These two factors 
are used together to determine the approximate quantity of amylase present in a sample. 
This information is then compared to known saliva, and non-saliva reference samples to 
determine the possible source of the unknown body fluid. One complication of using this 
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method is the interpretation of samples that are mixtures, which would have a varying 
concentration of amylase when compared to neat samples. Other tests such as the RSID-
saliva identification kit determines the presence of the enzyme α-amylase in evidentiary 
samples (Casey and Price, 2010)  
DNA Methylation Analysis 
 Compared to the progress that has been made for blood and semen identification, 
the literature regarding the identification of vaginal epithelial tissue and saliva are scanty.  
There have been several cases that support the validity of using methylation analysis for 
tissue identification. The first use of methylation analysis for forensic casework can be 
seen through the work of Frumkin et al. (2010) when the group developed an assay for 
the purpose of distinguishing artificial DNA from real DNA using methylation levels. 
The overall goal of such an assay was to increase the integrity of forensic DNA analysis, 
and as a result the group found that certain loci are consistently methylated where others 
are unmethylated. This fact opened the door to the possibility of distinguishing various 
forensically relevant tissue types using the same type of methylation analysis.  
In 2011, Frumkin et al. published their work regarding the use of DNA 
methylation levels to distinguish between tissue types. The group used 50 samples 
including blood, semen, saliva, and skin cells that were first digested with a methylation-
specific endonuclease, followed by amplification at specified regions and then analyzed 
using capillary electrophoresis.  Using this methodology, the group was able to identify 
the source tissue for each sample tested using the methylation percentages obtained.  
A study completed by Lee et al. (2011) further exemplified the ability to 
distinguish tissue types from one another using DNA methylation analysis. The study 
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investigated five differentially methylated regions (tDMR) of the DNA for the following 
sample types: saliva, blood, menstrual blood, vaginal fluid, and semen. Using bisulfite 
conversion methods, the group was able to determine that two of the markers in question 
were able to distinguish semen samples from all other tested sample types. Similarly, in a 
study conducted by Madi et al. (2012), four methylation markers were used to 
differentiate blood, saliva, and semen samples using pyrosequencing.    Methylation data 
at these tDMRs are normally investigated using bisulfite modification of the genomic 
DNA, site specific PCR amplification and pyrosequencing. Madi et al were able to 
identify a panel of markers, C20orf117, ZC3H12D, BCAS4, and FGF7, that can be used 
in the determination of blood, saliva, semen and skin epithelial cells. Both of the studies 
presented by Lee et al. (2011) and Madi et al. (2012) show that investigating these 
tDMRs provides a way to locate markers that can be used for tissue identification.  
In a broad study conducted by Park et al. (2014) the group was able to identify a 
large number of tDMRs using the Illumina HumanMethylation 450K bead array 
technology. Using this data, they were able to generate a list of the tDMRs for four 
different tissue types: saliva, blood, vaginal secretions, and semen.  In addition to 
publishing these potential sites Park et al. (2014) also investigated two sites for each of 
the tissue type. They found that the eight selected sites possessed the ability to distinguish 
each of the tissue type in question.  
It has become increasingly clear that DNA methylation can be used to distinguish 
tissue types from one another when the source of the sample is unknown. In a forensic 
point of view identifying the tissue source of a DNA sample is important because the 
presence or absence of a tissue may identify the type and severity of crime that took 
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place. Using the same bisulfite modification and pyrosequencing technology used by 
Madi et al. (2012), we hope to identify a set of novel saliva-specific CpG markers using 
potential candidate sites identified by Park et al. (2014).  
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CHAPTER III  - MATERIALS AND METHODS 
Sample Collection 
Samples of four types of biological fluids, blood, semen, vaginal epithelial cells, 
and saliva were collected from volunteers under the conditions of an approved 
Institutional Review Board (IRB) protocol at The University of Southern Mississippi. All 
donor samples were assigned a unique identifier number to help maintain confidentiality 
and anonymity of the samples.  
Blood samples were collected by first sterilizing the donor’s fingertip with 70% 
ethanol, and then pricking the finger with a sterile autolet lancet device. A sterile cotton 
swab was used to absorb the blood sample, which was air dried, labeled with unique 
number, and stored frozen at -20C.   
The saliva samples were collected by swabbing the inside of the cheek of the 
volunteer for approximately 30 seconds with a sterile cotton swab. The sample was air 
dried, labeled with unique number, and stored frozen at -20C. 
For semen sample collection, a sterile sample collection cup was provided to the 
participants who collected the sample themselves in a manner that is private and 
convenient to them. The donor then provided the sample to the researcher, who stored the 
sample at -20C freezer. 
 The vaginal epithelial samples were collected on a sterile cotton swab by the 
participant themselves in a manner that is convenient and comfortable to them. The 
sample was then returned to the researcher, labeled with a unique number, and stored in a 
-20C freezer. 
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DNA Extraction 
DNA was extracted using organic extraction techniques (Budowle, 2000). Cotton 
swabs containing samples of blood, saliva, or vaginal epithelial were separated from the 
applicator stick and placed in a labeled 1.5 mL tube. Each reaction contained 400 mL of 
stain extraction buffer, 10 microliters of Proteinase K, and was be incubated at 56°C 
overnight. After the incubation period is complete, the cotton swab was transferred to a 
new 1.5 mL tube containing a spin basket and centrifuged for five minutes at 12,000 rpm. 
The flow-through was placed back into the original 1.5 mL tube and the spin basket 
containing the cotton swab was discarded.  
25 microliters of each semen sample was added to a tube that contained a 
modified stain extraction cocktail; 150 microliters TNE (Tris/NaCl/EDTA), 50 
microliters of 20% Sarkosyl, 40 microliters of 0.39M dithiothreitol, 150 microliters of 
water, and 10 microliters of proteinase K solution and incubated at 37°C overnight. 
Following incubation, 500 mL of phenol/chloroform/isoamyl alcohol was added 
to each sample and briefly vortexed until a milky emulsion is obtained. Samples were 
centrifuged for 10 minutes at 12,000 rpm to separate the aqueous and organic phases into 
two distinct layers. The aqueous phase was removed from each sample, placed into a 
concentrator, and then spun at 5,000 rpm for approximately ten minutes. Following this 
initial spin, the flow-through was discarded and ~0.5 mL TE was added to the 
concentrator. The samples were centrifuged for ten minutes at 5,000 rpm; the washing 
steps were repeated three additional times for a total of four washes. The filter unit was 
then inverted into a clean 1.5 mL tube and centrifuged at 3,000 rpm for approximately 
three minutes. This DNA was stored at -20 °C until further testing. 
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DNA Quantitation 
 A 1% agarose gels was used to determine both the quantity and quality of the 
extracted DNA. 1 μL of a 1Kb ladder was loaded into the well of each row in the agarose 
gel. 2 μL of each sample combined with 2 μL of Bromophenol Blue (1:1 diluted) was 
loaded into each well and electrophoresed in a 1x TAE buffer at 120V for twenty 
minutes. The gel was stained for approximately 5 minutes in ethidium bromide and the 
band intensities were photographed using a UV transilluminator. The band sizes and 
intensity were compared to the standard ladder to determine the quantity and quality of 
each DNA sample.  
Bisulfite Conversion 
 Bisulfite conversions were performed using the recommended procedure provided 
with the Qiagen EpiTect Bisulfite Kit. Approximately 200 ng of genomic DNA were 
used for bisulfite conversion.  The bisulfite conversation process is described below: 
1. The components of each reaction for bisulfite conversion are listed in Table 1 
below. Each component was added to a 0.2 mL tube 
Component Volume per reaction (µL) 
DNA solution (1 ng-2 µg) Variable* (maximum 20 µL) 
Deionized water Variable* 
Bisulfite Mix solution 85 
DNA Protect Buffer 35 
Total volume 140 
    Table 1. Bisulfite conversion reaction components per sample  
       *The combined volume of DNA and water will total 20 microliters maximum 
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2. The samples were briefly vortexed, spun in the centrifuge, and placed in a 
thermalcycler.  
 
Table 2. Thermocycler conditions for bisulfite conversion. 
3. The program for bisulfite conversion is described in Table 2. 
Cleaning the Bisulfite Converted DNA 
1. Each sample was removed from the thermalcycler and the contents were 
transferred to a clean 1.5 mL tube 
2. 560 μL of loading buffer was added to the converted DNA, mixed and 
centrifuged gently. 
3. Samples were transferred to a spin column that is provided with the EpiTect 
Bisulfite Kit and centrifuged at 12,000 rpm for 1 minute. The flow-through for 
this spin was discarded. 
4.  500 μL of wash buffer was added to each tube. The samples were spun for 
one minute and the flow-through was discarded.  
5. 500 microliters of desulfonation buffer was added to each tube, and incubated 
at room temperature for 15 minutes. The samples were spun at 12,000 rpm for 
one minute, and the flow through liquid was discarded.  
Stage Duration (minutes) Temperature (°C) 
Denaturation 1 5 95 
Incubation 1 25 60 
Denaturation 2 5 95 
Incubation 2 85 60 
Denaturation 3 5 95 
Incubation 3 120 60 
Hold Indefinite 20 
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6. 500 microliters of wash buffer was added to each sample and centrifuged for 
one minute at 12,000 rpm, the liquid from the spin will be discarded. This step 
was repeated a second time, providing the samples with two total washes with 
the wash buffer.  
7. The columns were moved to new 2 mL tubes, centrifuged at 12,000 rpm for 1 
minute, and then incubated with open lids for 5 minutes at 56°C to promote 
evaporation of the liquid.  
8. The spin columns were placed in a new 1.5 mL tube and 20 μL of elution 
buffer was added directly onto the column. After one minute of incubation at 
room temperature, the samples were spun for one minute at 12,000 rpm. This 
step was repeated once more by adding another 20 μL elution buffer before 
centrifuging. The flow-through from these two spins contained the eluted 
bisulfite converted DNA.   
9. The 1.5 mL tubes were labeled and placed in the -20°C freezer until further 
analysis.  
Marker Selection and Primer Design 
 Park et al. (2014) has published the results of the Illumina 450k bead chip array 
data that contains potential CpG markers for multiple tissue identification.  Using this 
data, several promising CpG sites for saliva identification were selected. The CpG site 
location in the human genome was determined and the information was entered into the 
University of California Santa Cruz (UCSC) genome browser. 200 base pairs of DNA 
sequence both at the 5’ and 3’ of the CpG site were selected and downloaded from the 
browser.  This 400 base sequence was used to develop as assay for pyrosequencing using 
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the Pyromark assay design software (Qiagen Inc.) Ideally, the overall PCR product 
should be in the range of 100-200 base pairs.  
Amplification of CpG Sites for Pyrosequencing 
 At least 10 samples of bisulfite converted DNA for each tissue type were selected 
for PCR amplification. A PCR master mix was created as described in Table 3. 
Table 3. PCR components and corresponding volume for amplification per sample. 
Samples, along with a negative control, were placed in the thermocycler and a PCR 
amplification program was selected. This program is a cycling of three phases: 
denaturation, annealing of primer, and extension, and is described in Table 4.  
Table 4. Thermalcycler conditions for polymerase chain reaction amplification. 
To determine the success of amplification, a 2% agarose gel was used. A 100 bp ladder 
was loaded in the leftmost well of each row followed by 2µl of samples, and was 
Bisulfite-converted DNA 2 µL 
10x PCR Primer set 2 µL 
Coral load solution 2 µL 
Q-solution 4 µL 
2x Master Mix 10 µL 
Initial  
Incubation Step 
Denaturation Annealing Extension Final 
Extension 
Final Soak 
HOLD CYCLE (45 cycles) HOLD HOLD 
95ºC 
15 min 
94ºC 
30 sec 
Tm-5ºC 
30 sec 
72ºC 
30 sec 
72ºC 
10 min 
4ºC 
∞ 
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electrophoresed at 120 volts for 20 minutes in a 1x TAE buffer. The gel was stained in 
ethidium bromide solution and a UV transilluminator was used to visualize and 
photograph the gel.  
Pyrosequencing 
To begin pyrosequencing, an assay was created using Pyromark Q24 software. 
The same software was used to determine the amount of enzyme, substrate, and dNTPs to 
be added to the cartridge for the sequencing reaction.  
A cocktail containing 2 microliters of streptavidin beads, 20 microliters of water, 
and 40 microliters of binding buffer per sample was made. 62 microliters of cocktail was 
added to each well of a 24-well plate, along with 18 microliters of PCR product. The 
sample wells were covered with a strip cap and shaken at 1000 rpm for 10 minutes.  The 
24-well plate was removed from the shaker and the samples were processed using a 
vacuum workstation. The vacuum work station was used to lift the samples, washed with 
70% ethanol, denatured in NaOH solution and neutralized.  After processing, the samples 
were released into a pyrosequencing plate that contains 25 microliters of 1x sequencing 
primer in each well. The pyrosequencing plate was incubated for two minutes at 80°C, 
followed by 10 minutes at room temperature for annealing of the sequencing primers to 
the target.  
The pyrosequencing cartridge was prepared according to the quantities 
determined in the pre-run information from the Pyromark Q24 software. Following the 
addition of all materials to the pyrosequencer, the samples were ready to be sequenced.   
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Pyrosequencing Data Analysis  
Methylation data from the pyrosequencer was presented as a pyrogram, showing 
relative methylation percentages at each CpG site within the target region. This data was 
imported to an excel workbook where preliminary analysis was conducted regarding the 
average percent methylation at each site as well as the standard deviation. A histogram 
was created for each marker that includes the data from all four tissue types. Those sites 
that look promising for saliva differentiation were analyzed further using SPSS statistical 
analysis package software for the level of significance of the methylation data from 
different tissues.  A one-way ANOVA was used to compare the mean methylation levels 
of different tissues.  A p value of 0.05 or below (p<0.05) was considered significant.  
Species Specificity Test 
 The species specificity study involves testing of non-human samples using PCR 
and pyrosequencing. Several different species were tested using marker cg-9652652. The 
samples tested were cat, dog, chicken, cow, erythrobacter, chimp, rhesus, and a human 
control buccal sample. All genomic DNA samples were quantitated either by agarose gel 
or by human DNA quantifiler kit (Applied Biosystems), bisulfate modified and PCR 
amplified using the primers for the marker cg-9652652. The robustness of the 
amplification was tested using a 2% agarose gel. All samples were sequenced by 
pyrosequencing and the data was analyzed to determine if any species showed 
quantifiable methylation data   
Mixture study 
For the mixture study one semen sample and one saliva sample were used.  The saliva 
sample had hypermethylation and semen sample was hypomethylated. The two samples 
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chosen were based on success of previous PCR amplifications.  Each sample was diluted 
to a concentration of 10 ng/µl using TE buffer. Five different ratios of saliva v/s semen 
were set up, which include 90-10, 72-25, 50-50, 25-75 and 10-90. Each ratio contained a 
total combined amount of 100 ng of DNA, and was conducted in duplicate. After the 
mixture was created, the samples were bisulfite modified followed by and PCR 
amplification. A 2% gel was used to determine the success of the PCR amplification 
followed by pyrosequencing. The data for these mixtures were averaged and analyzed for 
any significant patterns. 
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CHAPTER IV – RESULTS 
The genomic DNA quantitation using agarose gel was performed to assess the 
quantity and quality of the DNA extracted from all tissues followed by bisulfate 
conversion, PCR and pyrosequencing. Ten or more samples per tissue type were used for 
pyrosequencing. The methylation analysis includes the average methylation of each CpG 
sites for each tissue types.   
Marker cg-9652652 
For the marker cg-9652652, ten or more samples per tissue type were used for 
methylation analysis. The methylation percentages for all CpG sites were analyzed using 
excel program.  The average and standard deviation data are shown in table 5.  
 
CpG_1 CpG_2 CpG_3 CpG_4 CpG_5 CpG_6 
Buccal 61.0 14.6 52.4  11.5 53.9  55.1 55.1  13.9 49.3  8.9 60.3  15.9 
Blood 14.8  14.5 12.5  11.6 12.5  12.4 14.4  15.1 11.1  10.4 13.7  14.3 
V. Epi 12.5  13 10.0  10.7 9.5  11.0 10.8  11.8 10.5  10.3 11.0  10.7 
Sperm 2.7  2.2  2.3  1.7 2.0  1.6 2.3  1.9 3.5  3.1 2.3  1.7 
Table 5. Percent Methylation and Standard Deviation for cg-9652652 
 The same methylation data are shown as a histogram in figure 1. 
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Figure 1. Histogram of average methylation data of marker cg-9652652. n=12 buccal; 10 
blood; 11 v.epi; 12 sperm. 
 
 The level of significance (p<0.05) in the methylation data between different 
tissues were calculated using SPSS statistical package with one-way ANOVA and 
tukey’s posthoc parameters. It was found that the methylation data for all CpG sites were 
significantly different (p = 0) compared to other tissues. 
Marker cg-11536474 
The average methylation data for the marker cg-11536474 for the four tissues 
studied are shown in table 6.   
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CpG_1 CpG_2 CpG_3 
Buccal 76.6  18.9 72.8  20.9 69.2  20.1 
Blood 10.4  8.4 10.5  12.1 8.1  8.5 
V. Epi 10.1  3.6 12.2  4.3 8.5  2.9 
Sperm 7.3  8.2 8.0  5.8 3.2  2.3 
Table 6. Percent Methylation and Standard Deviation for cg-11536474 
Figure 2 shows the methylation data for the four tissues for marker cg-11536474.  
 
Figure 2. Histogram of the average methylation data of marker cg-11536474. n=12 
buccal; 18 blood; 11 v.epi; 12 sperm. 
 
It was found that the methylation data for all CpG sites were significantly 
different (p = 0) compared to other tissues. This data suggests that the marker cg-
11536474 can be used to differentiate saliva from other tissues in forensic tissue 
identification.   
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Marker cg-3867465 
The average methylation data for the marker cg-3867465 for the four tissues 
studied are shown in table 7. 
 
CpG_1 CpG_2 CpG_3 CpG_4 CpG_5 
Buccal 47.6   11 54.4   13 
74.5  
15.7 
72.4  
14.7 
68.4   14.6 
Blood 4.1   2.2 5.6   2.6 10.1  5 9.8  5.2 6.0  1.7 
V. Epi 3.6   1.5 5.3  4.1 9.5  7.2 10.1  5.3 9.6  4.7 
Sperm 2.1  0.8 2.2  1.1 3.9  1.7 5.6  2.9 6.5  3.3 
Table 7. Percent Methylation and Standard Deviation for data for cg-3867465 
Figure 3 shows the methylation data for the four tissues for marker cg-3867465. 
 
Figure 3. Histogram of average methylation data of marker cg-3867465. n=11 buccal; 10 
blood; 11 v.epi; 11 sperm.  
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It was found that the methylation data for all CpG sites were significantly 
different (p = 0) compared to other tissues. This data suggests that the marker cg-
3867465 can be used to differentiate saliva from other tissues in forensic tissue 
identification.   
 Marker cg-10781408 
The average methylation data for the marker cg-10781408 for the four tissues 
studied are shown in tables 8.1 and 8.2.  
Table 8.1. Percent Methylation and Standard Deviation for cg-10781408 sites 1-6 
 
 
CpG_7 CpG_8 CpG_9 CpG_10 CpG_11 
Buccal 52  16.2 56  16.9 52  16.6 60  18.4 62.0  18.7 
Blood 3  1.7 2.5  0.8 7.0  3.1 4.0  1.4 3.0  1.1 
V. Epi 12  5.1 12.5  5.4 14.6  6.3 12.6  6.4 14.5  6 
Sperm 5.6  3.4 7.5  2.7 8.0 3.4 6.5  3.9 6.5  3 
Table 8.2. Percent Methylation and Standard Deviation for cg-10781408 sites 7-11 
 
CpG_1 CpG_2 CpG_3 CpG_4 CpG_5 CpG_6 
Buccal 72.0  18.9 75  19 68  20.2 77  19.8 52.5  17.6 56.0  17.5 
Blood 3.4  2.5 2.3  1.8 2.3  2 2.5  0.8 4  1.8 1  0.7 
V. Epi 16  6.7 15.2  6.7 12.6  6 18.4  7.4 16.8  5.7 11.3  5.1 
Sperm 5.8  4.5 4.3  2.2 3.9  3.3 4.8  3.2 15.3  9.6 3.8  2.1 
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Figure 4 shows the methylation data for the four tissues for marker cg-10781408.
 
Figure 4. Histogram of average methylation data of marker cg-3867465. n=12 buccal; 11 
blood; 11 v.epi; 12 sperm. 
 
It was found that the methylation data for all CpG sites were significantly 
different (p = 0) compared to other tissues. This data suggests that the marker cg-
10781408 can be used to differentiate saliva from other tissues in forensic tissue 
identification.  
Marker cg-10122865 
The average methylation data for the marker cg-10122865 for the four tissues 
studied are shown in table 9.   
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CpG_1 CpG_2 CpG_3 CpG_4 CpG_5 
Buccal 85.6  21.4 65.9  18.5 73.4  18.8 58.7  17.2 75.1  21.4 
Blood 7.2  2.4 5.2  1.6 2.6  1.9 3.5  4.1 5.8  3.2 
V. Epi 15.4  7.8 11.3  6 9.8  8.3 8.1  5.8 13.7  6.1 
Sperm 7.0  4.4 12.4  9 3.4  2.3 4.5  4 13.3  7.9 
Table 9. Percent Methylation and Standard Deviation for cg-10122865 
 
Figure 5. Histogram of average methylation data of marker cg-10122865. n=11 buccal; 
11 blood; 11 v.epi; 12 sperm.  
 
It was found that the methylation data for all CpG sites were significantly 
different (p = 0) compared to other tissues. This data suggests that the marker cg-
10122865 can be used to differentiate saliva from other tissues in forensic tissue 
identification.  
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Species Test 
In order to know the specificity of the primers to see if any other species will react 
with the human assay, several other organisms were tested.  For this purpose, the 
following samples were tested: cat, dog, chicken, cow, erythrobacter, chimp, and rhesus.  
When amplified for the marker cg9652652, only the chimp, and rhesus samples amplified 
that was detected with a 2% agarose gel.  All samples used in the amplification were 
sequenced regardless of amplification success.  Tables 10.1 and 10.2 show the 
methylation data obtained from different species. 
 CpG_1 CpG_2 CpG_3 CpG_4 CpG_5 
Chimp 6 2 2 3 1 
Rhesus 85 76 82 94 84 
BUC 147 88 75 73 80 59 
Table 10.1 Methylation data obtained for the different species, sites 1-5 
  
 CpG_6 CpG_7 CpG_8 CpG_9 
Chimp 2 7 7 2 
Rhesus 3 3 5 95 
BUC 147 77 58 78 84 
Table 10.2 Methylation data obtained for different species, sites 6-9 
The chimp sample was hypermethylated in all CpG sites tested while the rhesus 
sample produced mixed results, with CpG sites 1-5 and 9 being hypermethylated, and site 
6-8 hypomethylated. All other species tested did not produce any methylation data. These 
results show that the primers are human specific and can be used to identify human 
tissues in a forensic scenario.  
 32 
Mixture Study 
Often the samples submitted for forensic analysis are mixtures of two different 
individuals or samples of two different tissues. To study how a sample with two different 
body fluids mixed will behave in pyrosequencing, mixtures of two different body fluid 
DNA were prepared in different ratios (buccal versus sperm %): 90-10, 72-25, 50-50, 25-
75, and 10-90. All samples showed amplification bands of the right size and were 
pyrosequenced.  The methylation data of the different ratios for CpG site 2 in marker cg-
9652652 is shown in Figure 6. As expected, the methylation increased when the saliva 
sample is predominant and decreased when the sperm sample is predominant. 
 
Figure 6.  Methylation percent averages of mixed samples for cg-9652652, CpG site 2.  
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CHAPTER V – DISCUSSION 
Tissue identification in a forensic setting may provide vital information about the 
type and severity of a crime that has taken place. Coupled with DNA analysis, 
information could be gained that may determine the individual(s) who were present at the 
scene. The use of methylation analysis has received more attention in the recent decade 
as an alternate option for tissue identification (Frumkin et al., 2010; Frumkin et al., 2011; 
Lee et al., 2012; Madi et al., 2012; Park et al., 2014). DNA Methylation is an epigenetic 
process that can alter the gene function without changing the underlying DNA sequence 
itself. In previous years, DNA methylation has been studied for medicinal purposes, as 
methylation site proximity to the promotor region of genes control gene regulation.  (Li 
& Zhang, 2012; Previti et al., 2009). It has been determined that using bisulfite 
conversion followed by PCR and pyrosequencing can provide quantitative methylation 
levels of a CpG site. Pyrosequencing is a process that provides a ratio of converted to 
unconverted cytosine bases in a CpG site to determine the percent methylation of that site 
in question. The same analytical technique has been applied in the identification of four 
forensically-relevant tissue types: blood, semen, saliva, and vaginal epithelial tissue. Lee 
et al. (2012) and Madi et al. (2012) have used this pyrosequencing technology to study 
the methylation data for the identification of different tissues. In spite of the success of 
this technology, data regarding the identification of other tissues such as vaginal 
epithelial tissue and saliva are rare.  
 Therefore, this present study was undertaken to determine the usefulness of 
methylation data in differentiating saliva from three other forensically relevant tissues 
such as blood, semen and vaginal epithelia. In a study conducted by Park et al., (2014), 
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the investigators located a large number of potential CpG sites that can differentiate 
saliva from other tissues using Illumina 450K bed chip array technology. This 
preliminary data was used to study certain saliva specific markers that may be used for 
the differentiation of saliva from other tissues.   
Saliva identification: 
 Several potential CpG sites mentioned by Park et al (2014) were screened and 
five methylation markers were identified which showed promise in the differentiation of 
saliva from the other tissues. The identified markers were cg9652652, cg11536474, 
cg3867465, cg10781408, and cg10122865 along with additional CpG sites that flank 
these sites.  
 All the five markers mentioned above showed hypermethylation in saliva while 
the other tissues were hypomethylated.  The percent methylation levels between saliva 
and all other tissue types were found to be statistically significant (p<0.05) for all five 
markers tested, giving the conclusion that these five markers could be used to 
differentiate saliva from blood, semen, and vaginal epithelial samples.  
Species specificity of the markers: 
 In a forensic setup, identification of the species of origin of a tissue sample is 
important since the unknown crime scene samples may contain non-human DNA. To 
determine if the assay developed for the markers are human specific, one of the markers 
studied (cg9652652) was chosen to determine if non-human samples will amplify and 
provide any methylation data.  Several different species were tested including cat, dog, 
chicken, cow, erthyrobacter, chimp, rhesus, and a human control.  All samples were 
analyzed using pyrosequencing and only the chimp and rhesus samples gave usable 
 35 
methylation data.   It is not unexpected that the two primate samples amplified with the 
human specific primers because of the high similarity of the primate genome with that of 
humans. All other non-primate samples did not produce any methylation data and this 
proves that the PCR primers used in this study are human specific and will not interfere 
with non-human DNA samples. 
Mixture studies:   
 It is often possible that the DNA samples recovered from crime scenes are either 
mixture of two different individuals or of two different cell types. In order to study how a 
sample with two different cell type mixture behaves in their methylation content, a 
controlled mixture of two different cell types and of different ratios were studied. A 
sperm sample that was hypomethylated and a saliva sample that was hypermethylated 
were used. As theoretically expected, when the quantity of saliva was reduced, the 
methylation percent of the mixture also was reduced. These mixture studies help in 
deciphering of different components and quantity of each tissue type.  
 In addition to tissue identification, other studies have attempted to correlate the 
age of an individual and methylation (Weidner et al., 2014; Park et al., 2016; Alghanim et 
al., 2017). Some studies have reported the success in differentiating different age group 
individuals with methylation data (Jenkins et al., 2014, Vidaki et al., 2016). The ability to 
estimate age in a forensic setting when the source of a tissue sample is unknown would 
have significant implications.   
 Using methylation analysis for tissue identification over traditional serological 
tests has several advantages. First, traditional serological tests are used presumptively to 
determine if additional testing is warranted. Additional tests can lead to the consumption 
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of evidentiary material. For methylation analysis, the analyst does not have to extract the 
DNA separately because the DNA is already available for case work analysis.   
 Most traditional serological tests rely on the specific interaction of proteins within 
the tissue in question and the chemicals used for testing. The second advantage of 
methylation analysis for tissue differentiation is that this test relies on DNA, which is 
more stable that the protein used in serological analysis, and the proteins can degrade 
over a period of time.  Third, there is also a potential for multiplex kit development where 
more than one marker can be analyzed simultaneously either for tissue identification or 
age determination or a combination of both.  This would reduce the cost associated with 
individual marker analysis.   
 Limitations of this study include the influence of external factors such as age, 
smoking, diet, and obesity.  It has been reported that factors such as smoking and obesity 
contribute to the methylation status of an individual (Vidaki et al., 2013).  So, it should be 
kept in mind that external factors can contribute to the differences in methylation among 
the experimental population.   
In conclusion, it is determined that the five markers identified in this study have 
the potential to differentiate saliva from other forensically relevant tissues. Also, the 
primers used in the assay appear to be human specific with no interference of non-
primate samples. 
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APPENDIX A – Primer Specifications 
Marker Primer Sequence 
PCR 
Product 
Size 
Cg9652652 
Forward: GAGTTTTATTAGGGTTGAGTTTTT 
Reverse: CCCCAAATACCCCATTTCC 
Sequencing: AGTTTTATTAGGGTTGAGTTTTTT 
125 bp 
Cg11526474 
Forward: GAGTTAGGTTGTAGTAAAGTTT 
Reverse: ACTACCCCCCTATAAACCTCTAC 
Sequencing: GAGTTAGGTTGTAGTAAAGTTTT 
 
129 bp 
Cg3867465 
Forward TTTGGAGAGTTGAGTATTTGTGTGGTAAG 
Reverse: ACCTCTAACCCCTCTCAACAAACTCTAC 
Sequence: TGGTAAGAGGGGTTT 
 
150 bp 
Cg10781408 
Forward: GTAGTATAGGAAGTTTAGGTGGAAGA 
Reverse: ATCCAAACCTCACTCTCTATCC 
Sequencing: AGTTTAGGTGGAAGAG 
 
118 bp  
Cg10122865 
Forward: GGGGGTTAGGAGAGTTTAAGA 
Reverse: ACACCAAACCACCTTTTCT 
Sequencing: AGTTTAAGAAGTGGGG 
 
111 bp 
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